Patents by Inventor Unchalee Lodin

Unchalee Lodin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
    Patent number: 9060941
    Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.
    Type: Grant
    Filed: March 30, 2005
    Date of Patent: June 23, 2015
    Assignees: ACTAVIS, INC., TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Unchalee Lodin, Jack Cardinal, Avinash Nangia, Kazuhiro Okochi
  • Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
    Patent number: 8084058
    Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative and a disintegrating agent is herein disclosed and described. The dosage formulation exhibits a significant increase in bioavailability of the thiazolidinedione derivative component compared to conventional immediate release dosage forms containing only a thiazolidinedione derivative.
    Type: Grant
    Filed: March 30, 2005
    Date of Patent: December 27, 2011
    Assignees: Watson Pharmaceuticals, Inc., Takeda Pharmaceutical, Co. Ltd.
    Inventors: Unchalee Lodin, Jack Cardinal, Avinash Nangia
  • Controlled release sodium valproate formulation
    Patent number: 7713550
    Abstract: Disclosed is a controlled release formulation comprising valproic acid, pharmaceutically acceptable salt thereof, amide thereof, or derivative thereof.
    Type: Grant
    Filed: June 15, 2004
    Date of Patent: May 11, 2010
    Assignee: Andrx Corporation
    Inventors: Nilobon Podhipleux, Xiu Xiu Cheng, Unchalee Lodin, Chih-Ming Chen, Avinash Nangia, Dacheng Tian
  • Formulations including hygroscopic compounds
    Publication number: 20070231390
    Abstract: The invention is directed to dosage forms suitable for the administration of hygroscopic active agents.
    Type: Application
    Filed: March 29, 2006
    Publication date: October 4, 2007
    Applicant: Andrx Labs, LLC
    Inventors: Aaron Dely, Unchalee Lodin, Avinash Nangia
  • Controlled release sodium valproate formulation
    Publication number: 20050276850
    Abstract: Disclosed is a controlled release formulation comprising valproic acid, pharmaceutically acceptable salt thereof, amide thereof, or derivative thereof.
    Type: Application
    Filed: June 15, 2004
    Publication date: December 15, 2005
    Inventors: Nilobon Podhipleux, Xiu Cheng, Unchalee Lodin, Chih-Ming Chen, Avinash Nangia, Dacheng Tian
  • Sustained release dosage forms
    Publication number: 20050276849
    Abstract: The present invention is directed to sustained release neutralized divalproex sodium oral dosage forms, processes for preparing the same, and methods of treatment therewith.
    Type: Application
    Filed: June 15, 2004
    Publication date: December 15, 2005
    Inventors: Nilobon Podhipleux, Unchalee Lodin, Chih-Ming Chen, Avinash Nangia
  • Sustained release neutralized divalproex sodium
    Publication number: 20050276848
    Abstract: The present invention is directed to sustained release oral dosage forms comprising neutralized divalproex sodium, methods of manufacturing the dosage forms, and methods of treatment with the dosage forms.
    Type: Application
    Filed: June 15, 2004
    Publication date: December 15, 2005
    Inventors: Nilobon Podhipleux, Xiu Cheng, Unchalee Lodin, Chih-Ming Chen, Avinash Nangia, Dacheng Tian
  • Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
    Publication number: 20050249809
    Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative and a disintegrating agent is herein disclosed and described. The dosage formulation exhibits a significant increase in bioavailability of the thiazolidinedione derivative component compared to conventional immediate release dosage forms containing only a thiazolidinedione derivative.
    Type: Application
    Filed: March 30, 2005
    Publication date: November 10, 2005
    Inventors: Unchalee Lodin, Jack Cardinal, Avinash Nangia
  • Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
    Publication number: 20050226928
    Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.
    Type: Application
    Filed: March 30, 2005
    Publication date: October 13, 2005
    Inventors: Unchalee Lodin, Jack Cardinal, Avinash Nangia, Kazuhiro Okochi
  • Controlled release composition with semi-permeable membrane and poloxamer flux enhancer
    Publication number: 20050048119
    Abstract: A controlled release pharmaceutical tablet comprising a core containing the antihyperglycemic drug, a water soluble seal coat, a semipermeable membrane coating the core and at least one passageway in the membrane.
    Type: Application
    Filed: September 14, 2004
    Publication date: March 3, 2005
    Inventors: Avinash Nangia, Boyong Li, Aaron Dely, Unchalee Lodin, John Cardinal